Xiaochen Shu
Impact in
- Oncology top 10%
- Cancer Diagnosis and Treatment
- Cancer Risks and Factors
- Inflammatory Biomarkers in Disease Prognosis
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
Papers in
- Oncology 9
- Cancer Diagnosis and Treatment 4
- Cancer Risks and Factors 3
-
- Menopause: Health Impacts and Treatments 2
- Co-authors
- Kari Hemminki (15 shared papers)Jan Sundquist (14 shared papers)Jianguang Ji (11 shared papers)Sundquist Kristina (13 shared papers)Xinjun Li (5 shared papers)Balram Chowbay (1 shared paper)Boon Cher Goh (1 shared paper)Qingyu Stephanie Zhou (1 shared paper)
In The Last Decade
Xiaochen Shu
38 papers receiving 781 citations
Peers
Comparison fields: 5 of 69
- Oncology 251
- Pharmacology 78
- Physiology 130
- Internal Medicine 11
- Immunology 54
Countries citing papers authored by Xiaochen Shu
This map shows the geographic impact of Xiaochen Shu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaochen Shu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaochen Shu more than expected).
Fields of papers citing papers by Xiaochen Shu
This network shows the impact of papers produced by Xiaochen Shu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaochen Shu. The network helps show where Xiaochen Shu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaochen Shu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 104 | |
| 2 | 2010 | 97 | |
| 3 | 2009 | 72 | |
| 4 | 2009 | 66 | |
| 5 | 2009 | 64 | |
| 6 | 2023 | 64 | |
| 7 | 2010 | 55 | |
| 8 | 2011 | 29 | |
| 9 | 2010 | 26 | |
| 10 | 2019 | 18 | |
| 11 | 2010 | 17 | |
| 12 | 2014 | 14 | |
| 13 | 2011 | 12 | |
| 14 | 2011 | 12 | |
| 15 | 2023 | 12 | |
| 16 | 2019 | 11 | |
| 17 | 2022 | 11 | |
| 18 | 2008 | 10 | |
| 19 | 2012 | 10 | |
| 20 | 2016 | 9 |
About Xiaochen Shu
Xiaochen Shu is a scholar working on Oncology, Endocrinology, Diabetes and Metabolism, Genetics, Physiology and Anesthesiology and Pain Medicine, having authored 40 papers that have together received 803 indexed citations. Recurring topics across this work include Cancer Diagnosis and Treatment (4 papers), Bladder and Urothelial Cancer Treatments (3 papers), Genetic Associations and Epidemiology (3 papers), Cancer Risks and Factors (3 papers), Psoriasis: Treatment and Pathogenesis (2 papers), Metabolism, Diabetes, and Cancer (2 papers), Meningioma and schwannoma management (2 papers) and Menopause: Health Impacts and Treatments (2 papers). The work is most often cited by research in Oncology (251 citations), Pharmacology (78 citations), Physiology (130 citations), Internal Medicine (11 citations) and Immunology (54 citations). Xiaochen Shu has collaborated with scholars based in China, Sweden and Germany. Frequent co-authors include Kari Hemminki, Jan Sundquist, Jianguang Ji, Sundquist Kristina, Xinjun Li, Balram Chowbay, Boon Cher Goh, Qingyu Stephanie Zhou, Soo Chin Lee and Srinivasa Rao Jada. Their work appears in journals such as Annals of Oncology, British Journal of Cancer, Journal of Oncology, European Journal of Cancer Prevention and European Journal of Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.